-
BHQ: A Translational Lens on SERCA and HSC Mobilization
2026-08-24
A mechanistic and translational analysis of 2,5-di-tert-butylbenzene-1,4-diol (BHQ) as a SERCA perturbation tool, integrating calcium homeostasis, ER stress, vascular physiology, and emerging evidence for hematopoietic stem cell mobilization.
-
Rotenone and the Energy Logic of Autophagy
2026-08-24
Rotenone is a mitochondrial Complex I inhibitor that reveals how bioenergetic stress can reshape apoptosis and autophagy interpretation. This article connects rotenone-based mitochondrial assays with the AMPK–ULK1 energy-stress framework and practical Parkinson’s disease research decisions.
-
Self-Assembling EVMPs for Extrahepatic mRNA Delivery
2026-08-23
The reference study introduces a bottom-up enveloped virus-mimicking particle (EVMP) that combines engineered self-assembling peptides with selected phospholipid envelopes to direct mRNA beyond the liver. Its optimized formulation produced substantial lung-cell transfection and suppressed tumor progression after delivery of IL-12 mRNA, while highlighting a modular strategy for tissue-selective mRNA delivery.
-
ERCC1 Deficiency, p53, and Cisplatin Response
2026-08-22
Heyza and colleagues used CRISPR-Cas9-engineered lung cancer models to show that ERCC1 loss does not produce a uniform platinum response: p53 status strongly influences apoptosis, survival, and interstrand crosslink repair. The study identifies DNA-PKcs and BRCA1 as contributors to cisplatin tolerance in ERCC1-deficient cells, refining how ERCC1 should be interpreted as a biomarker.
-
2X Taq PCR Master Mix for C. elegans Studies
2026-08-22
Build faster C. elegans genotyping, cloning, and sequence-validation workflows with a ready-to-use 2X Taq PCR Master Mix that includes direct-loading dye. Its adenine-overhang chemistry supports TA cloning, while the simplified gel workflow helps connect genetic perturbations to pheromone-driven neurodegeneration experiments.
-
AZD1390: From ATM Inhibition to G4 Stress
2026-08-21
Explore how AZD1390, a selective ATM kinase inhibitor, can sharpen interpretation of radiation and replication-stress assays. This article connects ATM checkpoint signaling with new REV1–DHX36 findings while clearly separating validated evidence from testable hypotheses.
-
Ruxolitinib phosphate: JAK/STAT Assay Workflows
2026-08-20
Build more informative pathway studies with Ruxolitinib phosphate, a selective JAK1/JAK2 tool for cytokine signaling inhibition, inflammatory models, and cancer research. This guide translates recent anaplastic thyroid carcinoma findings into practical assay design, controls, optimization steps, and troubleshooting strategies.
-
LNP Trafficking, Endosomal Entrapment, and Escape
2026-08-20
This study shows that lipid nanoparticle delivery depends not only on cellular uptake but also on where nanoparticles accumulate along the endolysosomal pathway. By combining sensitive LNP labeling with controlled endolysosomal states, the authors identify peripheral endosome entrapment as a barrier to trafficking and suggest that perinuclear lysosomal compartments can support productive cytosolic release.
-
Forskolin and the Translational Logic of cAMP Control
2026-08-19
Forskolin is more than a routine cAMP reagent: as a direct adenylate cyclase activator, it can help translational researchers separate pathway responsiveness from model-specific trafficking, differentiation, and inflammatory effects. This article connects Forskolin biology with recent CFTR trafficking findings and provides a practical framework for rigorous cross-model validation.
-
Vorinostat and mRNA Lipoplex Protein Expression
2026-08-19
Tang and Hattori examined whether the histone deacetylase inhibitor vorinostat alters protein production after firefly luciferase mRNA lipoplex delivery. Low-dose vorinostat enhanced expression in HeLa and HepG2 cells, whereas its effects on tissue distribution and luciferase output after intravenous administration in mice were limited and context-dependent.
-
Camostat Mesilate and Translational Inhibition Logic
2026-08-18
A mechanistic and strategic guide to using Camostat Mesilate across ENaC biology, plasmin–TGF-β signaling, hepatic fibrosis models, and assay-informed translational research—while distinguishing protease inhibition from structure-guided antiviral PPI design.
-
Osteoblast ECM1 and Enzalutamide Resistance
2026-08-18
The reference study identifies osteoblast-derived ECM1 as a microenvironmental driver of enzalutamide resistance in bone metastatic prostate cancer. It connects ECM1 to ENO1 phosphorylation, GRB2/SOS1 recruitment, and MAPK activation, while showing that ECM1 or ENO1 inhibition can restore anti-androgen sensitivity.
-
Oltipraz Workflows for Nrf2 and MASLD Research
2026-08-17
Build a controlled Nrf2 induction workflow with Oltipraz to connect phase II enzyme responses with autophagy, ferroptosis, lipid stress, and liver injury readouts. The defined small molecule complements complex botanical interventions by making concentration, timing, and pathway attribution easier to test.
-
X-Gal Workflows for Cloning and Reporter Validation
2026-08-17
Use X-Gal as a fast visual checkpoint for blue-white colony screening, plasmid quality control, and qualitative β-galactosidase reporter workflows. This guide connects practical molecular cloning decisions with findings from olfactory receptor research while clearly separating established use from exploratory assay design.
-
Azithromycin B1398: Reliable Assay Design
2026-08-16
Azithromycin B1398 supports controlled bacterial infection research, resistance testing, and carefully interpreted viability workflows. This scenario-based guide explains mechanism, solvent compatibility, concentration selection, data interpretation, and practical supplier evaluation.